Okyo Pharma
London
About Okyo Pharma
Okyo Pharma focuses on novel GPCR based therapeutics for eye diseases of high unmet need and non-opioid analgesics for chronic pain.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $33.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: nasdaq:OKYO
- Website: okyopharma.com
- Phone: +44 0207-495-2379
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/okyo-pharma-125890 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.